Literature DB >> 29921992

Cardiopulmonary Bypass in the Setting of Waldenström's Macroglobulinemia.

Brandon D D'Aloiso1, Sarah S Rupchak1, Kaitlin J Gettle1, Claudio Lima1, Robert D Rush1.   

Abstract

Waldenström's Macroglobulinemia (WM) is a rare lymphoma caused by the overproduction of immunoglobulin M (IgM). The elevated level of IgM causes serum hyperviscosity, cold agglutinins, and cryoglobulinemia. Anemia is also present because of impaired production of erythrocytes. For these reasons, placing a patient with WM on cardiopulmonary bypass (CPB) requires careful preparation. In this case, the patient was a 73-year-old male with known Waldenström's disease who required coronary artery bypass graft surgery. This report details the perioperative considerations used for successful CPB on a Waldenström's patient. Critical to this case was the use of plasmapheresis before surgery. Temperature management and acid/base status were carefully controlled. A successful coronary revascularization surgery was performed. Many of the Wadenstrom's disease complications expected on CPB failed to materialize.

Entities:  

Keywords:  Waldenström’s Macroglobulinemia; cardiopulmonary bypass; cold agglutinins; hyperviscosity

Mesh:

Substances:

Year:  2018        PMID: 29921992      PMCID: PMC6002643     

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  6 in total

Review 1.  Waldenström's macroglobulinemia: clinical features, complications, and management.

Authors:  M A Dimopoulos; P Panayiotidis; L A Moulopoulos; P Sfikakis; M Dalakas
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

Review 2.  Evidence-based focused review of management of hyperviscosity syndrome.

Authors:  Marvin J Stone; Steven A Bogen
Journal:  Blood       Date:  2011-12-06       Impact factor: 22.113

3.  Waldenstrom's disease and cardiopulmonary bypass: a case report.

Authors:  Claire A Sweeting; Noel Kelleher; Nilofer Mahmood; Jonathan Unsworth-White; Mike Weatherall; Gerry Webb
Journal:  Perfusion       Date:  2004-11       Impact factor: 1.972

Review 4.  Role of plasmapheresis in Waldenström's macroglobulinemia.

Authors:  Marvin J Stone; Steven A Bogen
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-03-20

Review 5.  Optimal perfusion during cardiopulmonary bypass: an evidence-based approach.

Authors:  Glenn S Murphy; Eugene A Hessel; Robert C Groom
Journal:  Anesth Analg       Date:  2009-05       Impact factor: 5.108

6.  The combination of mannitol and albumin in the priming solution reduces positive intraoperative fluid balance during cardiopulmonary bypass.

Authors:  I R Jenkins; A P Curtis
Journal:  Perfusion       Date:  1995-09       Impact factor: 1.972

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.